El Gezira and Sennar states in central Sudan are experiencing severe medicine shortages and price increases. According to medicine supplier Ibrahim Osman, the two states are facing persistent transport problems, multiple levies, exchange-rate fluctuations, and higher import costs. These challenges have resulted in stagnation and sharp price increases in the medicine market. The pharmaceutical sector is particularly vulnerable to overlapping economic and logistical crises, making it difficult to import, transport, and distribute medicines.
The medicine crisis in El Gezira and Sennar states is exacerbated by the ongoing war in Sudan, which has weakened the role of the National Medical Supplies Fund in providing medicines. Osman cites inadequate government funding as a major issue, as the state budget is directed towards the war effort. This has undermined the ability of relevant institutions to meet pharmaceutical needs, leading to shortages of essential medicines, including insulin. The health insurance system is also facing serious problems, further complicating access to medical care.
The situation is particularly dire in hot regions where epidemics and diseases such as dengue fever, malaria, and typhoid are spreading. These illnesses require substantial quantities of medicines, intravenous fluids, and painkillers, which are in short supply. Osman warns that medicine shortages are particularly dangerous in these regions, where infection and death rates are already high. The shortage of medicines is also affecting patients with chronic illnesses, who are struggling to obtain treatment.
The parallel market for medicines is expanding as supplies through official channels decline and prices rise. This has raised concerns about whether patients can obtain treatment amid the continuing war, declining purchasing power, and rising medicine costs. Osman notes that the pharmaceutical sector faces several pressures, including fuel shortages, global conditions, and tensions surrounding the Strait of Hormuz. These factors have made it increasingly difficult to import, transport, and distribute medicines.
The crisis in El Gezira and Sennar states highlights the need for urgent action to address the medicine shortage and price hikes. The National Medical Supplies Fund and the health insurance system must be strengthened to ensure that patients have access to essential medicines. The government must also address the underlying causes of the crisis, including the war, transport issues, and currency fluctuations. Until then, patients in El Gezira and Sennar states will continue to suffer.
The medicine crisis in Sudan is not limited to El Gezira and Sennar states. The entire country is affected by the shortage of medicines and the rising costs of healthcare. The situation is likely to worsen unless urgent action is taken to address the root causes of the crisis. Osman and other stakeholders are calling for immediate intervention to mitigate the effects of the medicine shortage and ensure that patients have access to life-saving medicines.
The international community has a role to play in supporting Sudan’s healthcare system during this crisis. Humanitarian organizations and donors can provide critical assistance, including medicines, medical supplies, and funding for healthcare programs. The Sudanese government must also prioritize healthcare and allocate sufficient resources to address the medicine shortage and other healthcare challenges. By working together, it is possible to mitigate the effects of the crisis and ensure that patients in Sudan have access to quality healthcare.
Key points
- Medicine shortages and price hikes plague El Gezira and Sennar states in Sudan due to transport issues, multiple levies, and currency fluctuations.
